EUROEYES (01846) announced its interim results, reporting a loss attributable to shareholders of HKD 13.561 million, reversing from profit to loss compared to the same period last year.

20:39 31/08/2026

The company Devision Group (01846) announced its interim results for the six months ended June 30, 2026, reporting earnings of HKD 454 million, an increase of 20.5% year-on-year; the loss attributable to the company's owners was HKD 13.561 million, a year-on-year turnaround from profit to loss; the loss per share was HKD 0.04254.

EUROEYES (01846) announced its interim results for the six months ended June 30, 2026, reporting revenue of HKD 454 million, an increase of 20.5% year-on-year; the loss attributable to the owners of the company was HKD 13.561 million, a shift from profit to loss compared to the previous year; the loss per share was HKD 0.04254. The announcement stated that the significant expansion of presbyopia correction treatments and the inclusion of the Swiss business were the main factors driving revenue growth.

BJ HEALTH (02389) announced its interim results, reporting a shareholder loss of HKD 31.797 million, an increase of 8.76% year-on-year.

KAISA GROUP (01638) announced its interim results, with a loss attributable to shareholders of approximately 9.3285 billion yuan, a year-on-year decrease of about 7%.

EDA GROUP HLDGS (02505) released its interim results, reporting a net loss attributable to shareholders of 42.16 million yuan, compared to a profit in the same period last year.

BJ HEALTH (02389) announced its interim results, reporting a shareholder loss of HKD 31.797 million, an increase of 8.76% year-on-year.

KAISA GROUP (01638) announced its interim results, with a loss attributable to shareholders of approximately 9.3285 billion yuan, a year-on-year decrease of about 7%.

EDA GROUP HLDGS (02505) released its interim results, reporting a net loss attributable to shareholders of 42.16 million yuan, compared to a profit in the same period last year.